Does RANOLAZINE Cause Stent placement? 593 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 593 reports of Stent placement have been filed in association with RANOLAZINE (Ranolazine). This represents 6.2% of all adverse event reports for RANOLAZINE.
593
Reports of Stent placement with RANOLAZINE
6.2%
of all RANOLAZINE reports
1
Deaths
325
Hospitalizations
How Dangerous Is Stent placement From RANOLAZINE?
Of the 593 reports, 1 (0.2%) resulted in death, 325 (54.8%) required hospitalization.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 593 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
Nausea (266)
What Other Drugs Cause Stent placement?
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
FLUTICASONE\SALMETEROL (105)
Which RANOLAZINE Alternatives Have Lower Stent placement Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ